PureTech Health plc (LON:PRTC – Get Free Report) passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 208.38 ($2.57) and traded as high as GBX 219.50 ($2.71). PureTech Health shares last traded at GBX 218 ($2.69), with a volume of 749,098 shares traded.
PureTech Health Trading Up 2.6 %
The company has a current ratio of 7.31, a quick ratio of 2.51 and a debt-to-equity ratio of 25.41. The firm has a fifty day simple moving average of GBX 208.38 and a two-hundred day simple moving average of GBX 185.86. The firm has a market cap of £588.49 million, a PE ratio of -1,676.92 and a beta of 0.94.
About PureTech Health
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.
Featured Articles
- Five stocks we like better than PureTech Health
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- 3 Stocks Leading the U.S. Agriculture Comeback
- Investing in large cap stocks: Diving into big caps
- How to Use Put Debit Spreads to Profit From Falling Stocks
- 3 REITs to Buy and Hold for the Long Term
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
